NCT00405171View on ClinicalTrials.gov

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

February 28, 2006

Conditions

HIV InfectionsHypercholesterolemiaAntiretroviral Therapy

Interventions

DRUG

Nevirapine

Trial Locations (1)

14033

Côte de Nacre University hospital, Caen

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University Hospital, Caen

OTHER